Related Experiment Video

Updated: Aug 9, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Correction: Condorelli et al. Nano-Hybrid Au@LCCs Systems Displaying Anti-Inflammatory Activity. Materials 2022, 15,

Marcello Condorelli1, Antonio Speciale2, Francesco Cimino2

  • 1Department of Chemical Sciences, University of Catania, V.le A. Doria 6, 95125 Catania, Italy.

Materials (Basel, Switzerland)
|September 9, 2022
PubMed
Summary

This study corrects previously published findings. The updated research ensures accuracy in scientific reporting and data integrity.

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis07:30

Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis

Published on: March 7, 2018

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...